ClinicalTrials.gg
RecruitingNCT06736756Updated Dec 17, 2024

Impact of Tensor Fascia Lata Stretch on Vastus Medialis Obliqus Activity

An observational study in Patellofemoral Pain Syndrome, sponsored by Ahram Canadian University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2024-12-17.

Sponsored by Ahram Canadian University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Sep 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
37
Ages
18 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Patellofemoral Pain Syndrome with a site in Egypt — 9 open to participants now, 11 under way, none of them phase 3. Patellofemoral Pain Syndrome · Egypt.

Started
2024
with 4 others
Observational
8 of 26
2 open now
Primary completion
2024-12
later than 1 of 10 live
Registered
14th of 26
by date
Lead sponsor
4 of 26
Ahram Canadian University

Among the 26 studies in Patellofemoral Pain Syndrome with a site in Egypt, this one is one of 5 that started in 2024, is one of 8 observational ones, reaches primary completion later than 1 of the 10 other live ones, and was the 14th registered.

Patellofemoral Pain Syndrome

297 studies on the registry are indexed under Patellofemoral Pain Syndrome; 73 are open to participants now.

Browse Patellofemoral Pain Syndrome studies →

Open to participants now

9 of the 26 studies in Patellofemoral Pain Syndrome with a site in Egypt are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 44 Patellofemoral Pain Syndrome studies recruiting now, 3 (7%) set no upper age limit and 40 (91%) stop at 75 or younger; 6 take children under 18; 12 take healthy volunteers.

This study: 18 Years to 30 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Patellofemoral Pain Syndrome with a site in Egypt, or all of them as a file.
02

Study summary

Patellofemoral pain syndrome (PFPS) is one of the most typical causes of anterior knee pain in adolescents and young adults under the age of 50.It is believed that imbalanced action between quadriceps components, is the most contributing cause of PFPS.Investigating exercises that increase VMO muscle activation and enhance the ratio between VMO and VL have been a standardized target in literature.

Read the detailed description

Participants will have the assessed limb ready by shaving the hair on thigh and using alcohol swabs to clean the area from any residues.

For the VMO, a surface EMG electrode will be placed 4 cm superior and 4 cm medial to the supromedial boarder of patella at approximately 55 degrees to the long axis of the femur. As for the VL, the electrode will be placed 10 cm superior and 6-8 cm lateral to the superior lateral boarder of the patella and orientated 15 degrees to the vertical. All electrodes are self-adhesive (Figure 8) and will be connected to EMG sensors that will be attached and secured by double-sided tape.Each participant will perform three consecutive squats with 5 seconds interval break between each repetition. The squat depth will be kept at 50 degrees knee flexion. Mean muscle activity from three squat repetitions of VMO and VL is recorded and VMO:VL ratio is calculated. Afterward, each participant will perform the TFL stretch and repeat the three squats again.

03

Conditions studied

  • Patellofemoral Pain Syndrome
04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients referred from orthopedic surgeon with diagnosis of PFPS

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Both genders.
  2. (BMI) ranges from 18.5 to 29.9.
  3. Age ranges between 18 and 30 years old.
  4. Experience nontraumatic anterior knee pain.
  5. Pain with any two activities, including running, jumping, squatting, kneeling, stair ascent/descent or prolonged sitting.
  6. Having at least one positive PFPS clinical tests including, patellofemoral compression, patellofemoral gliding or resistive quadriceps setting

Exclusion criteria

Exclusion Criteria:

  1. Coexisting pathology around the knee, including patellar subluxation or dislocation.
  2. Previous knee surgery.
  3. Suspicion of patellar tendinopathy, with strong consideration of pain localised to the patellar tendon.
  4. Patients didn't receive physiotherapy treatment or use of non-steroidal anti-inflammatory drugs for knee pain in the previous 3 months.
  5. Any neurological or rheumatic disorders
  6. Pain intensity more than 5 (based on visual analogue scale)
  7. Hip and ankle pathology.
  8. more than 30%.
  9. Pregnancy.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
37 participants (estimated)
Patient registry
No

Interventions

  • OtherStretch Exercise

    To stretch Tensor fascia lata muscle,each participant starts with side lying position with the tested limb upmost. The lower limb (non-tested) is kept in hip and knee flexion to ensure stability. The tested limb is then taken into hip extension and adduction with knee extended. The exercise is held for 60 seconds and repeated 5 times with 10 seconds break intervals.

06

What researchers measure

Primary outcomes

  1. VMO muscle activity

    VMO muscle activity during squat is assessed by EMG device

    Time frame: During the procedure

Secondary outcomes

  1. VMO to VL ratio

    Ratio between VMO and VL activity during squat

    Time frame: Immediately after the procedure

07

Study locations

1 of 1 sites recruiting
  • Tasneem Khaled
    Cairo, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2024 (actual). Primary completion is estimated for Dec 2024, 3 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 7, 2024
First posted
Dec 17, 2024
StartActual
Sep 30, 2024
Primary completionEst.
Dec 2024
CompletionEst.
Apr 2025
Last update
Dec 17, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06736756
Lead sponsor
Ahram Canadian University
Responsible party
Tasneem Khaled Fouad Abdelghany (Teaching Assistant Orthopedic department, Ahram Canadian University) — Principal investigator
First posted
Dec 17, 2024
Start date
Sep 30, 2024
Primary completion
Dec 2024 (estimated)
Completion
Apr 2025 (estimated)
Last update
Dec 17, 2024

Study contacts

Tasneem Abdelghany, Bachelor
Contact
tasnim.khaled@acu.edu.eg
01015507353
Enas Fawzy, Professor
principal investigator · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion